Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015748
Filing Date
2024-11-14
Accepted
2024-11-14 17:00:29
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elut-20240930x10q.htm   iXBRL 10-Q 2242516
2 EX-31.1 elut-20240930xex31d1.htm EX-31.1 15135
3 EX-31.2 elut-20240930xex31d2.htm EX-31.2 15103
4 EX-32.1 elut-20240930xex32d1.htm EX-32.1 6780
5 EX-32.2 elut-20240930xex32d2.htm EX-32.2 6720
  Complete submission text file 0001558370-24-015748.txt   9356403

Data Files

Seq Description Document Type Size
6 EX-101.SCH elut-20240930.xsd EX-101.SCH 64100
7 EX-101.CAL elut-20240930_cal.xml EX-101.CAL 55779
8 EX-101.DEF elut-20240930_def.xml EX-101.DEF 302129
9 EX-101.LAB elut-20240930_lab.xml EX-101.LAB 580752
10 EX-101.PRE elut-20240930_pre.xml EX-101.PRE 454625
83 EXTRACTED XBRL INSTANCE DOCUMENT elut-20240930x10q_htm.xml XML 1577341
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
ELUTIA INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 241463960
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)